EUVIMEDEUVIMED entdecken
Kommentar

Targeting drug-tolerant persister cells: Let’s bring on the TROPs!

Motohiro Izumi, Susumu S Kobayashi, Balazs Halmos

Cancer Cell · 2026-07 · 44 (7) · 1333-1335

DOI: 10.1016/j.ccell.2026.05.019 ↗

Kurz gefasst

Kommentar in der Zeitschrift Cancer Cell, 2026-07. Verfasst von Motohiro Izumi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine III, Wakayama Medical University, Wakayama, Japan; Center for Biomedical Sciences, Wakayama Medical University, Wakayama, Japan. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Cell Adhesion Molecules, Protein Kinase Inhibitors, Lung Neoplasms. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this issue of Cancer Cell, Liao et al. identify TROP2 as an EGFR tyrosine kinase inhibitor-induced vulnerability in drug-tolerant persister lung cancer cells. They show that anti-TROP2 antibody-drug conjugates target this residual population, supporting an "induce-target-kill" strategy to delay resistance and extend the benefit of EGFR tyrosine kinase inhibition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmCell Adhesion MoleculesProtein Kinase InhibitorsLung NeoplasmsImmunoconjugatesHumansErbB ReceptorsAntineoplastic AgentsAnimalsAntigens, Neoplasm

Substanzen

ErbB ReceptorsCell Adhesion MoleculesProtein Kinase InhibitorsTACSTD2 protein, humanAntineoplastic AgentsImmunoconjugatesAntigens, Neoplasm

Autor:innen und Institutionen

  • Internal Medicine III, Wakayama Medical University, Wakayama, Japan; Center for Biomedical Sciences, Wakayama Medical University, Wakayama, Japan.
  • Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo,…
  • Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: bahalmos@montefiore.org.

Zitieren

APA

Izumi, M., Kobayashi, S. S., & Halmos, B. (2026). Targeting drug-tolerant persister cells: Let’s bring on the TROPs!. Cancer Cell, 44(7), 1333-1335. https://doi.org/10.1016/j.ccell.2026.05.019

Vancouver

Izumi M, Kobayashi SS, Halmos B. Targeting drug-tolerant persister cells: Let’s bring on the TROPs!. Cancer Cell. 2026;44(7):1333-1335. doi:10.1016/j.ccell.2026.05.019

BibTeX
@article{Izumi2026,
  author = {Izumi, Motohiro and Kobayashi, Susumu S and Halmos, Balazs},
  title = {Targeting drug-tolerant persister cells: Let’s bring on the TROPs!},
  journal = {Cancer Cell},
  year = {2026},
  volume = {44},
  number = {7},
  pages = {1333--1335},
  doi = {10.1016/j.ccell.2026.05.019}
}
Kostenlos starten →